官方服务：
资源简介：
Are describes patents of anti-OX40 antibodies
应用场景：
创建时间：
2019-02-15
相关数据集
Table_4_Characterizing and correcting immune dysfunction in non-tuberculous mycobacterial disease.xlsx
Non-tuberculous mycobacterial pulmonary disease (NTM-PD) is a chronic, progressive, and growing worldwide health burden associated with mounting morbidity, mortality, and economic costs. Improvements
NIAID Data Ecosystem110
Table_4_A Computational Approach Identifies Immunogenic Features of Prognosis in Human Cancers.XLSX
A large number of tumor intrinsic and extrinsic factors determine long-term survival in human cancers. In this study, we stratified 9120 tumors from 33 cancers with respect to their immune cell conten
NIAID Data Ecosystem30
North America VISTA Antibody Market
The report on North America VISTA Antibody covers a summarized study of several factors supporting market growth, such as market size, market type, major regions, and end-user applications. The report
IMR REPORTS20
ILT3 (LILRB4) Promotes the Immunosuppressive Function of Tumor-Educated Human Monocytic Myeloid-Derived Suppressor Cells
Myeloid-derived suppressor cells (MDSCs) are immature myeloid cells that accumulate in the tumor microenvironment (TME). MDSCs have been shown to dampen anti-tumor immune responses and promote tumor g
NIAID Data Ecosystem60
Expression data from EBV+ and EBV- plasmablastic lymphomas
We produced and analyzed the transcriptomic profiles of agressive plasmablastic lymphomas to describe their "immune escape" profile, depending on their viral status (HIV, EBV, ...). We used microarray
NIAID Data Ecosystem30
